Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

morning brief

- PMLiVE

GSK persuades NICE to reconsider negative Benlysta decision

Decision on lupus drug referred to expert committee following appeal

Bristol-Myers Squibb (BMS) building

BMS halts hep C candidate development after patient death

Promises to share drug data to assist other pharma companies’ patient safety measures

Kai Gait returns to GSK as digital marketing director

He will be developing digital channel materials and services, built on customer insights

Bristol-Myers Squibb (BMS) building

BMS halts trial of hepatitis C drug on safety issues

At least one person in study thought to have developed congestive heart failure

- PMLiVE

GSK’s Olympic doping facility to research personalised medicines after Games

MRC-NIHR Phenome Centre is “phenomenal legacy” from London 2012 says MRC’s Prof John Savill

GSK and other Olympic sponsors may face hacking attack

IT security firm claims ‘hacktivist’ network Anonymous could target websites of London 2012 partners

GSK pay $3bn to settle drug-marketing case

UK drug-maker pleads guilty for promoting a number of drugs in the US off-label

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links